Catalog No. A3966

Doxorubicin

(别名:多柔比星;阿霉素

拓扑异构酶II(Topo II)抑制剂,免疫抑制抗肿瘤抗生素。

Doxorubicin
规格价格货期数量
1mL(10 mM in DMSO)
¥500.00
现货
10mg
¥545.00
现货
25mg
¥763.00
现货
100mg
¥1745.00
现货
CAS号:23214-92-8纯度:99.72%
仅用于科研,不用于诊疗。未经明确授权不得转售。
A
021-55669583sales@apexbio.cnAPExBIO

特色产品

Annexin V-FITC/PI Apoptosis Kit
Annexin V-FITC/PI Apoptosis Kit
用于双染检测细胞凋亡和坏死
- 在10-20分钟内完成染色
- 适用于流式细胞仪和荧光显微镜检测
- 准确区分活细胞/凋亡细胞/坏死细胞
Phos binding reagent (Phosbind) acrylamide
Phos binding reagent (Phosbind) acrylamide
分离和检测磷酸化/非磷酸化蛋白
- 新型的磷酸盐结合标签和功能分子
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8)
用于细胞增殖和细胞毒性试验
- 比MTT,MTS或WST-1更敏感
- 对细胞无毒性
- 步骤更简单,无需有机溶剂
Cy5 TSA Fluorescence System Kit
Cy5 TSA Fluorescence System Kit
Cy5荧光标记的酪胺信号放大系统
- 检测ICC/IHC/ISH中的低丰度靶点
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
用于观察mRNA运送,定位,翻译
- 具有Cap1结构的荧光素酶mRNA
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
HotStart™ 2X Green qPCR Master Mix
HotStart™ 2X Green qPCR Master Mix
用于荧光定量目标DNA或cDNA
- 通过热启动机制优化扩增特异性
- 优异的扩增效率、可重复性和稳定性
- 卓越的灵敏度和准确性,操作简单
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
高效的Cy5修饰RNA转录试剂盒
- 适合原位/Northernblot杂交实验
- 优化的缓冲液和T7 RNA聚合酶混合物
- 20 μL反应体系可获得更高的RNA产量

产品描述

Doxorubicin(多柔比星)是从细菌培养物中分离的半合成抗癌剂[1],是一种蒽环类抗生素,被广泛用于血液癌症、实体瘤和肉瘤。

Doxorubicin插入DNA双链中,抑制DNA拓扑异构酶II的运动,停止复制过程[2]。Doxorubicin也诱导组蛋白从开放的染色质中驱逐,引起DNA损伤和表观遗传失调[3]。

Doxorubicin通过静脉给药。将近75%的doxorubicin及其代谢物与血浆蛋白结合。Doxorubicin不能穿过血脑屏障。50%的药物主要通过胆汁排泄从身体中消除,剩下的药物经过单电子还原、二电子还原和去糖苷化,其主要代谢物是一种有效的膜离子泵抑制剂,与心肌病相关[4]。

参考文献:
[1]Brayfield, A, ed.  (2013). Doxorubicin. Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 15 April 2014.
[2]Pommier Y. , et al. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chemistry & Biology 17 (5): 421–433.
[3]Pang, B. , et al. (2013). Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nature Communications 4 (5): 1908
[4]Boucek RJ. , et al. (1987). The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. A correlative study of cardiac muscle with isolated membrane fractions. J of Biol Chem 262: 15851-15856.

产品性质

物理外观A solid
CAS号23214-92-8
分子式C27H29NO11
分子量543.52
化学名称(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
溶解度≥27.2 mg/mL in DMSO; insoluble in EtOH; ≥24.8 mg/mL in H2O with ultrasonic
SMILESOC=1C2=C([C@@H](O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C[C@@](C(CO)=O)(O)C2)C(O)=C4C1C(=O)C=5C(C4=O)=C(OC)C=CC5
存储条件-20℃ 密封,避光
运输条件蓝冰
注意事项

(1)粉末对光照、高温敏感;(2)溶液现用现配;(3)注射液开封后立即使用,避免长时间暴露在光照下。

产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)

IC50和靶点

生物活性描述Doxorubicin(Adriamycin)是一种抗生素;DNA拓扑异构酶II的抑制剂;DNA损伤和细胞凋亡的诱导剂。

生物相关数据

质量控制

操作说明

常见问题

Q:血清肌钙蛋白I(TnI)检测无明显升高,是什么原因?

A:根据文献报道,DOX诱导的TnI升高是短暂的——造模后3天可能出现轻微升高,7天即可恢复正常;若想检测到TnI升高,需在造模后3天采集血清,7天检测主要看心肌萎缩和心功能,而非TnI。(参考文献:DOI: 10.1161/CIRCHEARTFAILURE.118.005234)

APExBIO 顾客使用本产品发表的 40 篇科研文献

1. Nima Daneshvar Baghbadorani, Mira Bosso, et al. "A 3D Collagen-Based In Vitro Cancer Model Created Through Modular Tissue Engineering." Cancers (Basel). 2026 Mar 13;18(6):935. PMID: 41899540

2. Tatjana Maravic, Giulia Petrucci, et al. "In Vitro Study of Cold Atmospheric Plasma–Induced Proliferation Inhibition and Morphological Changes in Head and Neck Carcinoma Cell Lines." J Dent. 2025 Jul 29:161:106007. PMID: 40744292

3. Yue Wang, Chen Wei, et al. "A pH-sensitive peptide amphiphilic-based drug delivery system inhibits hepatocellular carcinoma growth by suppressing hepatic stellate cell activation." Mater Today Bio. 2025 Apr 30:32:101821. PMID: 40453820

4. Ting Gao, Yufeng Tang, et al. "Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α." Adv Sci (Weinh). 2025 May 24;12(25):2414504. PMID: 40411250

5. Xuan Wang, Qiqi Sun, Jianrong Li, Baoyong Lai, Xiaohua Pei, Nana Chen et al. "Effect of Fangxia-Dihuang Decoction on doxorubicin-induced cognitive impairment in breast cancer animal model." Front Oncol. 2025 Apr 28:15:1515498. PMID: 40356765

6. Lishuang Cui, Qing Xia, et al. "Luteolin - 7 - O - glucuronide alleviates doxorubicin - induced cardiotoxicity by inhibiting PPAR - mediated ferroptosis." Toxicol Appl Pharmacol. 2025 Jul:500:117381. PMID: 40345555

7. Ning Wang, Chenxi Qiao, et al. "Acetylation of Short Glycopeptides Enables Phase Separation." Biomacromolecules. 2025 Mar 10;26(3):1595-1603. PMID: 39903822

8. Kun Li, Kun-Mao Jiang, et al. "Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities." Int Immunopharmacol. 2025 Feb 6:147:114016. PMID: 39805175

9. Eduard Reznik, Fereshteh Zandkarimi ,Joleen M. Csuka. "Lipidomic changes in persister cancer cells drive enhanced ferroptosis sensitivity." Ferroptosis Oxid Stress. 2025;1:202501

10. N Daneshvar Baghbadorani, M Bosso, et al. "A novel in vitro 3D cancer model based on modular tissue engineering approach." bioRxiv. March 01, 2025

11. Asena Aynaci, Maxence Toussaint, et al. "Disruption of Man-6-P-Dependent Sorting to Lysosomes Confers IGF1R-Mediated Apoptosis Resistance." Int J Mol Sci . 2025 Apr 10;26(8):3586

12. Wenli Xie, Qing Xia, et al. "Structural characterization and cardioprotective activities of natural polysaccharides from Apocynum venetum L." Chem. Biol. Technol. Agric. 12, 81 (2025)

13. Aimei Li, Xue Tian, et al. "Alkaline phosphatase-responsive peptide amphiphiles promote the apoptosis of HER2-positive breast cancer cells via increased drug accumulation." Colloids and Surfaces A: Physicochemical and Engineering Aspects. Volume 718, 5 August 2025, 136848

14. Siyuan Li, Wencheng Zhang, et al. "Serum sSelectin-L is an early specific indicator of radiation injury." Heliyon. 2024 May 8;10(10):e30527. PMID: 38778981

15. Yixuan Li, Fanfan Guo, et al. "Marein, a novel natural product for restoring chemo-sensitivity to cancer cells through competitive inhibition of ABCG2 function." Biochem Pharmacol. 2024 Apr 21:116219. PMID: 38643907

16. Ji-Hye Song, Min-Sun Kim, et al. "Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection." Phytomedicine. 2024 Jul:129:155633. PMID: 38640859

17. Ivonne González-Gamboa, Adam A Caparco, et al. "Inter-coat protein loading of active ingredients into Tobacco mild green mosaic virus through partial dissociation and reassembly of the virion." Sci Rep. 2024 Mar 26;14(1):7168. PMID: 38532056

18. Weili Li, Jing Cao, et al. "Aucubin Alleviates Doxorubicin-Induced Cardiotoxicity Through Crosstalk between NRF2 and HIPK2 Mediating Autophagy and Apoptosis." Phytomedicine. 2024 May;127:155473. PMID: 38422972

19. Baiying Lei, et al. "Morphology-based deep learning enables accurate detection of senescence in mesenchymal stem cell cultures." BMC Biol. 2024 Jan 2;22(1):1. PMID: 38167069

20. Min Wang, Fang Zhou, et al. "The transcription factor PPARA mediates SIRT1 regulation of NCOR1 to protect damaged heart cells." Cardiovascular Diagnosis & Therapy Vol 14, No 5 (October 31, 2024)

21. Shudan Wang, Mingcai Chen, et al. "Shexiang Baoxin Pills alleviate doxorubicin-induced cardiotoxicity via the reactive oxygen species-mediated AKT/Bcl-2 pathway." Published in Medicine 27 December 2024

22. Sookil Tae, Hye Yeon Lee, et al. "Senolytic and Senomorphic Effects of Lactobacillus plantarum DS0037 Derived Exosome-like Nanovesicles." Journal of the Society of Cosmetic Scientists of Korea Volume 50 Issue 4 / Pages.335-348 / 2024 / 1226-2587(pISSN) / 2288-9507(eISSN)

23. Meng Wang, Dongfang Xie, et al. "Multiple ingredients of a Chinese medicine formula Sheng-Mai-San coordinately attenuate doxorubicin-induced cardiotoxicity." Pharmacological Research - Modern Chinese Medicine. Volume 8, September 2023, 100281

24. Riley Plett, Paul Mellor, et al. "Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel." Sci Rep. 2022 Sep 19;12(1):15663. PMID: 36123435

25. Boqin Hu, Dong Zhen, et al. "Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells." J Ethnopharmacol. 2022 Apr 24;288:114936. PMID: 35007682

26. Hai-Bing Yang, Zhao-Yang Lu, et al. "Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway." Biol Trace Elem Res. 2021 Aug 30. PMID: 34462843

27. Ji Yun Lee, Joo Hyun Kim, et al. "EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma." Sci Rep. 2021 May 14;11(1):10342. PMID: 33990633

28. Zhongying Gong, Xiaoying Liu, et al. "Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy." Colloids Surf B Biointerfaces. 2021 Mar 4;202:111673. PMID: 33714186

29. Wang X, Wang Q, et al. "TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity." J Exp Clin Cancer Res. 2020;39(1):93. PMID: 32448281

30. Gong Z, Lao J, et al. "pH-Triggered geometrical shape switching of a cationic peptide nanoparticle for cellular uptake and drug delivery." Colloids Surf B Biointerfaces. 2020;188:110811. PMID: 31982793

31. Qi W, Boliang W, et al. "Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling." Biomed Pharmacother. 2020;122:109547. PMID: 31918264

32. Gong Z, Shi Y, et al. "Plasma Amine Oxidase-Induced Nanoparticle-to-Nanofiber Geometric Transformation of an Amphiphilic Peptide for Drug Encapsulation and Enhanced Bactericidal Activity." ACS Appl Mater Interfaces. 2020;12(4):4323–4332. PMID: 31899611

33. Gong Z, Liu X, Wu J, et al. "pH-triggered morphological change in a self-assembling amphiphilic peptide used as an antitumor drug carrier." Nanotechnology. 2020;31(16):165601. PMID: 31891937

34. Ji Yun Lee, Joo Hyun Kim, et al. "Gene Expression Profiling in Extranodal NK/T-Cell Lymphoma." Research Square. December 4th, 2020

35. Yan L, Ding B, et al. "Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma." Theranostics. 2019 Oct 22;9 (26):8377-8391. PMID: 31754403

36. Wang Z, Chen J, et al. "cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity." J Clin Invest. 2019 Aug 13;130:4850-4862. PMID: 31408442

37. Wang X, Li C, et al. "Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1." Cancers (Basel). 2019 Jun 28;11(7). pii: E910. PMID: 31261758

38. Zhang Y, Xia F, et al. "miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2." J Exp Clin Cancer Res. 2019 Jan 21;38(1):26. PMID: 30665445

39. Goodspeed A, Jean A, et al. "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer." Eur Urol. 2019 Feb;75(2):242-250. PMID: 30414698

40. Deng Y, Li F, et al. "Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition." Mol Carcinog. 2018 Jun;57(6):807-814. PMID: 29500880

摩尔浓度计算器

质量
= 浓度
x 体积
x 分子量
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Apexbio的产品页面获得)批次特异的分子量使用本工具。
产品目录
产品目录
质量认证
产品目录
联系我们
通讯
获取最新资讯,产品折扣和优惠。
Copyright ©2013-2026 APExBIO Technology. All Rights Reserved.沪公网安备 31011002003500沪公网安备 31011002003500沪ICP备14019579号-3